Reuters: Hot Stocks: BRIEF-Idenix Pharma drops in premarket after FDA puts second hepatitis C drug on hold

Reuters: Hot Stocks Reuters.com is your source for breaking news, business, financial and investing news, including personal finance and stocks. Reuters is the leading global provider of news, financial information and technology solutions to the world's media, financial institutions, businesses and individuals. // via fulltextrssfeed.com

BRIEF-Idenix Pharma drops in premarket after FDA puts second hepatitis C drug on hold Aug 27th 2012, 13:09 NEW YORK | Mon Aug 27, 2012 9:09am EDT NEW YORK Aug 27 (Reuters) - Idenix Pharmaceuticals Inc : * Idenix Pharmaceuticals drops 15 percent to $5.10 in premarket after FDA puts second hepatitis C drug on hold

You are receiving this email because you subscribed to this feed at blogtrottr.com. If you no longer wish to receive these emails, you can unsubscribe from this feed, or manage all your subscriptions